Clinical trial
Multimodal Markers of Neurodegenerative Disorders at Presymptomatic Stages
NCT06516016 is registered in ClinicalTrials.gov with Paris Brain Institute (ICM) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multimodal Markers of Neurodegenerative Disorders at Presymptomatic Stages
- Lead sponsor
- Paris Brain Institute (ICM)
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- September 1, 2024
- Completion date
- August 31, 2034
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.